Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Bevacizumab 35 Paclitaxel 31 Carboplatin 24 pembrolizumab 23 Specimen Handling 21 Magnetic Resonance Spectroscopy 19 Gemcitabine 18 olaparib 16 liposomal doxorubicin 16 Cyclophosphamide 15 fludarabine 12 Topotecan 12 Biopsy 12 niraparib 11 Cisplatin 10 Taxes 8 Nivolumab 8 Immunoglobulin G 8 Fulvestrant 8 Disulfides 8 Doxorubicin 7 aldesleukin 6 Surveys and Questionnaires 6 palbociclib 5 Oxaliplatin 5 Fluorouracil 5 trastuzumab deruxtecan 4 oregovomab 4 mirvetuximab soravtansine 4 X-Rays 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × senaparib × 90 days × Clear all

NCT07586449 2026-05-14

RESO

Zhejiang Cancer Hospital

Not yet recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡